Robert Jones, MD,PhD

Professor of Medical Oncology
Cardiff University and Velindre Cancer Centre

I am currently Specialty Lead for Cancer in Wales, Early Phase Cancer Trials Lead for Wales, Clinical Director of Research at Velindre Cancer Centre, and Professor of Medical Oncology at Cardiff University.

I am dual trained in Medicine and Science. I carried out my Medical Degree in Oxford and then trained as a Medical Oncologist in Glasgow. I completed my PhD in Nic Jones’s laboratory in London, and have carried out short research spells with Paul Russell and Frank McCormick in California.

After a CRUK Clinician Scientist Fellowship I joined Cardiff in 2009. I set up Wales's only Cancer Phase 1 Trials Unit and opened its first ever First in Human Trial and led Global recruitment on it. Having evolved from a zero starting point we now have a team of around 20 staff. I have been Principal Investigator of around 35 Early Phase Trials and I am Chief Investigator on two Investigator Led National Portfolio trials, FAKTION and FURVA. FURVA was reported at the European Society of Medical Oncology meeting (2020) and FAKTION at the American Society of Clinical Oncology (Chicago 2019). FAKTION received significant media coverage https://www.youtube.com/watch?v=4DkiQaKzAIg&feature=youtu.be.

Disclosure information not submitted.

Presentation(s):

• MP27-13: Long-term Safety of Darolutamide Among Patients With Metastatic Castration-resistant Prostate Cancer Who Received More Than 4 Years of Therapy

  Saturday, May 14, 2022
  10:30 AM – 11:45 AM